14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $27.14 $33.02 Wednesday, 24th Apr 2024 AGIO stock ended at $31.67. This is 0.440% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 3.00% from a day low at $31.32 to a day high of $32.26.
90 days $21.66 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
Feb 12, 2024 $25.27 $25.98 $24.75 $25.88 970 810
Feb 09, 2024 $24.25 $25.17 $24.25 $25.14 688 130
Feb 08, 2024 $23.76 $24.31 $23.70 $24.18 512 870
Feb 07, 2024 $24.08 $24.08 $23.43 $23.69 400 778
Feb 06, 2024 $23.89 $24.48 $23.71 $24.15 503 627
Feb 05, 2024 $22.85 $23.81 $22.41 $23.73 525 916
Feb 02, 2024 $22.60 $23.28 $22.50 $23.09 616 745
Feb 01, 2024 $22.71 $23.00 $22.23 $22.96 472 069
Jan 31, 2024 $22.79 $23.33 $22.51 $22.62 545 463
Jan 30, 2024 $23.73 $23.86 $22.66 $22.86 606 956
Jan 29, 2024 $23.27 $24.08 $22.72 $23.87 586 986
Jan 26, 2024 $23.48 $23.66 $22.92 $23.38 626 941
Jan 25, 2024 $21.77 $23.45 $21.66 $23.42 1 105 034
Jan 24, 2024 $21.80 $21.99 $21.18 $21.51 580 667
Jan 23, 2024 $22.15 $22.15 $21.37 $21.71 350 188
Jan 22, 2024 $21.89 $22.31 $21.29 $21.62 523 915
Jan 19, 2024 $21.41 $21.80 $20.96 $21.73 4 585 071
Jan 18, 2024 $21.80 $21.80 $21.02 $21.32 671 187
Jan 17, 2024 $21.77 $22.11 $21.40 $21.71 716 217
Jan 16, 2024 $22.57 $22.70 $21.76 $21.94 865 147
Jan 12, 2024 $22.94 $23.32 $22.44 $22.74 551 180
Jan 11, 2024 $22.93 $23.13 $22.40 $22.59 618 160
Jan 10, 2024 $23.99 $24.40 $23.13 $23.40 591 127
Jan 09, 2024 $24.15 $24.21 $23.52 $24.00 474 658
Jan 08, 2024 $23.04 $24.46 $22.65 $24.45 618 184
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT